Education
About Us
Working with TipRanks
Follow Us
James Mccullough Insider Profile
4 Followers
James Mccullough, Chief Executive Officer at Renalytix, holds 3.24M shares in Renalytix (Ticker: RENXF). Most recently, James Mccullough Bought $25,000 shares of Renalytix on Dec 11, 2024 for an estimated value of 2.13K.
James Mccullough Renalytix (RENXF)Chief Executive Officer
Renalytix (RENXF)
Chief Executive Officer
Ranked #87,891 out of 100,956 Corporate Insiders
Profitable Transactions
4 out of 8 Profitable Transactions
Average Return
-24.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of James Mccullough's holdings
Insider Roles
Chief Executive Officer
Roles that James Mccullough holds in companies
Most Profitable Insider Trade
The most profitable trade made by James Mccullough
James Mccullough's Trading History
List of latest transactions for each holding click on a transaction to see James Mccullough's performance on stock
You May Also Like
James Mccullough insider profile FAQ
What is the percentage of profitable transactions made by James Mccullough?
The percentage of profitable transactions made by James Mccullough is 50%.
What is the average return per transaction made by James Mccullough?
The average return per transaction made by James Mccullough is -24.20%.
What stocks does James Mccullough hold?
James Mccullough holds: RENXF stocks.
What was James Mccullough’s latest transaction?
James Mccullough latest transaction was an Informative Buy of $2.13K.
What was James Mccullough's most profitable transaction?
James Mccullough’s most profitable transaction was an Informative Sell of RENXF stock on May 21, 2021. The return on the trade was 40.90%.
What is James Mccullough's role in Renalytix?
James Mccullough's role in Renalytix is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.